Your browser doesn't support javascript.
loading
Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome.
Huang, Wenjie; Navarro-Serer, Bernat; Jeong, Yea Ji; Chianchiano, Peter; Xia, Limin; Luchini, Claudio; Veronese, Nicola; Dowiak, Cameron; Ng, Tammy; Trujillo, Maria A; Huang, Bo; Pflüger, Michael J; Macgregor-Das, Anne M; Lionheart, Gemma; Jones, Danielle; Fujikura, Kohei; Nguyen-Ngoc, Kim-Vy; Neumann, Neil M; Groot, Vincent P; Hasanain, Alina; van Oosten, A Floortje; Fischer, Sandra E; Gallinger, Steven; Singhi, Aatur D; Zureikat, Amer H; Brand, Randall E; Gaida, Matthias M; Heinrich, Stefan; Burkhart, Richard A; He, Jin; Wolfgang, Christopher L; Goggins, Michael G; Thompson, Elizabeth D; Roberts, Nicholas J; Ewald, Andrew J; Wood, Laura D.
Afiliação
  • Huang W; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Navarro-Serer B; Hepatic Surgery Center, Tongji Medical College, Huazhong University of Science and Technology, Clinical Medicine Research Center for Hepatic Surgery of Hubei Province, Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China.
  • Jeong YJ; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Chianchiano P; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Xia L; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Luchini C; Department of Gastroenterology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Veronese N; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, Italy.
  • Dowiak C; National Institute of Gastroenterology-Research Hospital, IRCCS "S. de Bellis", Castellana Grotte, Bari, Italy.
  • Ng T; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Trujillo MA; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Huang B; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Pflüger MJ; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Macgregor-Das AM; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Lionheart G; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Jones D; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Fujikura K; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Nguyen-Ngoc KV; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Neumann NM; Department of Cell Biology, Center for Cell Dynamics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Groot VP; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Hasanain A; Department of Cell Biology, Center for Cell Dynamics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • van Oosten AF; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Fischer SE; Department of Surgery, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Gallinger S; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Singhi AD; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Zureikat AH; Department of Laboratory Medicine and Pathobiology, University of Toronto, University Health Network, Toronto, Canada.
  • Brand RE; Department of Surgery, University of Toronto, University Health Network, Toronto, Canada.
  • Gaida MM; Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Heinrich S; Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Burkhart RA; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • He J; Institute of Pathology, University Medical Center Mainz, JGU-Mainz, Germany.
  • Wolfgang CL; General, Visceral and Transplantation Surgery, University Hospital of Mainz, Mainz, Germany.
  • Goggins MG; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Thompson ED; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Roberts NJ; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Ewald AJ; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Wood LD; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Cancer Res ; 80(13): 2804-2817, 2020 07 01.
Article em En | MEDLINE | ID: mdl-32376602
ABSTRACT
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by extensive local invasion and systemic spread. In this study, we employed a three-dimensional organoid model of human pancreatic cancer to characterize the molecular alterations critical for invasion. Time-lapse microscopy was used to observe invasion in organoids from 25 surgically resected human PDAC samples in collagen I. Subsequent lentiviral modification and small-molecule inhibitors were used to investigate the molecular programs underlying invasion in PDAC organoids. When cultured in collagen I, PDAC organoids exhibited two distinct, morphologically defined invasive phenotypes, mesenchymal and collective. Each individual PDAC gave rise to organoids with a predominant phenotype, and PDAC that generated organoids with predominantly mesenchymal invasion showed a worse prognosis. Collective invasion predominated in organoids from cancers with somatic mutations in the driver gene SMAD4 (or its signaling partner TGFBR2). Reexpression of SMAD4 abrogated the collective invasion phenotype in SMAD4-mutant PDAC organoids, indicating that SMAD4 loss is required for collective invasion in PDAC organoids. Surprisingly, invasion in passaged SMAD4-mutant PDAC organoids required exogenous TGFß, suggesting that invasion in SMAD4-mutant organoids is mediated through noncanonical TGFß signaling. The Rho-like GTPases RAC1 and CDC42 acted as potential mediators of TGFß-stimulated invasion in SMAD4-mutant PDAC organoids, as inhibition of these GTPases suppressed collective invasion in our model. These data suggest that PDAC utilizes different invasion programs depending on SMAD4 status, with collective invasion uniquely present in PDAC with SMAD4 loss.

SIGNIFICANCE:

Organoid models of PDAC highlight the importance of SMAD4 loss in invasion, demonstrating that invasion programs in SMAD4-mutant and SMAD4 wild-type tumors are different in both morphology and molecular mechanism.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Organoides / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Carcinoma Ductal Pancreático / Proteína Smad4 Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Organoides / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Carcinoma Ductal Pancreático / Proteína Smad4 Idioma: En Ano de publicação: 2020 Tipo de documento: Article